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INTRODUCTION
The existence of autonomous protein synthesis in
the mitochondria of eukaryotic cells has been well
established (1, 2). The mitochondrial protein syn-
thesis system has been characterized in unicellular
organisms such as yeast, Neurospora, etc. (3-7) .
More recently, the protein synthesis system of
mammalian mitochondria has been partially char-
acterized (8-19). The active unit of this system
appears to be a 55S (20) particle which occurs
assembled into 95S structures (18) . In mammalian
cells this system produces a small number of
polypeptides, perhaps six or seven (21) .
Several specific inhibitors of mitochondrial-spe-
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cific RNA and protein syntheses are available .
Ethidium bromide inhibits mitochondrial RNA
synthesis at very low concentrations. The drug has
little effect on the synthesis of RNA occurring
outside of mitochondria (22). It also inhibits mito-
chondria) DNA replication' and rapidly reduces
mitochondrial protein synthesis to immeasurable
levels (19). Chloramphenicol is a specific and
complete inhibitor of mitochondrial protein syn-
thesis but has little effect on other cellular synthetic
processes (11, 18, 19, 23, 24) .
HeLa cells in suspension culture continue to
I Leibowitz, R. Manuscript in preparation.
541grow for two generations in the presence of con-
centrations of ethidium bromide or chloramphen-
icol which almost completely inhibit mitochondrial
protein synthesis (90%0). The effects of such growth
on mitochondrial structure and cell morphology
have been examined .
MATERIAL AND METHODS
HeLa cells were grown in suspension culture as pre-
viously described. Ethidium bromide was present in
the medium at a concentration of 0.5 yg/ml, or
chloramphenicol at 50 µg/ml . The cells were diluted
every day and the cell concentration never exceeded
4 X 105 cells/ml.
Several fixation methods were employed, but the
most satisfactory results were obtained from the
following. Cells were collected by centrifugation at a
speed of 800 rpm for 10 min in an International Pr-2
centrifuge (International Equipment Co., Needham
Heights, Mass.) higher speeds yielded disrupted
cells. The cell pellets were washed by resuspension
in Earle's saline (25) and collected again. The pellets
were then fixed for 1 hr in 2 .5% glutaraldehyde
buffered with 0.1 M cacodylic acid, and then were
washed for 2 hr in 0.2 M sucrose buffered with caco-
dylate (26). Postfixation with 2% osmium tetroxide
buffered with sodium barbital (27) was followed
with a 30 min wash in 0 .5% uranyl acetate (28, 29) .
The pellets were dehydrated in ethanol and washed
for 15 min in propylene oxide (30). A mixture of
two parts Epon B to one part Epon A (30) was intro-
duced to the pellets through graded concentrations
of propylene oxide. The pellets were then embedded
in this same Epon mixture. Thin sections were cut
on a Sorvall Porter-Blum ultramicrotome MT-2 and
stained with 0.5% uranyl acetate (31) for 2.5 min,
followed by lead citrate (32) for 2 min . Electron
micrographs were taken with a Siemens Elmiskop I.
RESULTS
HeLa cells growing in suspension culture show a
well-defined and reproducible growth response to
either of the two agents used here. The cell genera-
tion time rises from 24 hr to greater than 48 hr.
The cell number always increases by a factor of
four after 4 days of incubation. After this time,
growth ceases and obvious cellular disintegration
sets in.
Fig. 1 shows the growth of control and ethidium
bromide-treated cells. Cells grow more slowly in
the presence of the inhibitor but the population
does eventually increase by a factor of four . Both
light microscopy and electron microscopy indicate
that the drug-treated cells are about the same size
as control cells, indicating an increase in cell mass
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FIGURE 1 The effect of ethidium bromide on
the growth of HeLa cells. Suspension cultures
of HeLa cells were initially at 2 X 10 6 cells/ml.
Ethidium bromide was added at 0 .5 gg/ml
to one culture. Cultures were diluted daily so
that cell concentration never exceeded 4 X 10 6
cells/ml. The relative number of cells repre-
sents cumulative growth and not the actual
concentration in the culture . The same growth
curve is obtained with chloramphenicol.
as well as number. Essentially the same growth
curve is obtained with chloramphenicol .
Fig. 2 shows a typical section from control cells
which have been stained so as to accentuate the
cristae of the mitochondria. The mitochondria re-
semble those previously described by other in-
vestigators (33, 34) . This figure may be compared
to Fig. 3 which shows a section from cells incubated
for 3 days in chloramphenicol. The effect on the
cristae of mitochondria is quite dramatic ; there
are many fewer mitochondrial cristae than in
control cells. A similar result has been obtained
previously with the mitochondria from yeast
treated with chloramphenicol (24). The inner mi-
tochondrial membrane appears to have a drasti-FIGURE 2 Control cells. Note the frequent occurrence of cristae in mitochondria . X 24,000.
543FIGURE 3 Cells incubated 3 days in chloramphenicol. Note distorted inner mitochondrial membrane
and relatively scarce cristae . CM, circular inner mitochondrial membrane ; Vac, vacuoles presumably
containing lipids; Go, Golgi-like lamellar structure; D, dark-staining bodies. X 48,000.
544cally altered organization and it no longer forms
the folds or cristae characteristic of normal mito-
chondria. Especially interesting is the occur-
rence of circular inner membranes where the
structures have apparently broken loose from much
of the outer mitochondrial membrane . These cir-
cular membranes are characteristic of drug-treated
cells and are not seen in control cells .
The inhibition of mitochondrial-specific macro-
molecular metabolism eventually has significant
effects on the morphology of the cell cytoplasm.
Droplets apparently containing lipids appear scat-
tered through the cytoplasm of the drug-treated
cells shown in Fig. 3. These droplets are rarely seen
in control cells. Also, after this long period of treat-
ment, numerous dark-staining objects of unknown
significance are found . While these objects occur
within 1 day after drug treatment, they increase
in number until cell growth stops.
Since cell mass has increased by a factor of four,
it is possible to ask whether mitochondrial mass
has been diluted by this factor. A qualitative esti-
mate of the number of mitochondria and the
contour length of the outer membrane indicates
that, in fact, the mitochondrial mass is approxi-
mately the same in control and drug-treated cells.
Thus the formation of organelles identifiable as
mitochondria apparently does not depend upon
mitochondrial-specific protein synthesis .
DISCUSSION
The amount of genetic information contained in
the mammalian mitochondrial genome is limited
and appears to code for only a few different poly-
peptides (21 ; S. Penman, unpublished) . Most of
the mitochondrial-specific enzymes must therefore
be synthesized in the cell cytoplasm under the
direction of nuclear genes. Preliminary results in
this and other laboratories indicate that the syn-
thesis of some mitochondrial-specific enzymes ap-
parently ceases in the cell after the administration
of either ethidium bromide or chloramphenicol .
Presumably, the proteins synthesized in the mi-
tochondria are necessary for the continued pro-
duction or stabilization of mitochondrial proteins
which are synthesized outside of the mitochon-
dria. As the cells grow in the presence of the
drug, mitochondrial activities such as cytochrome
oxidase are gradually diluted out.
It appears that, despite the inhibition of forma-
tion of normal mitochondrial structure in the
presence of the two inhibitors studied here, cells
continue to grow for a limited time, presumably by
using the pre-existing mitochondrial proteins. An
increase in cell mass by a factor of four, however,
appears to exhaust this pre-existing capacity and
cells thereafter enter a phase of rapid degradation.
These results suggest that the outer mitochon-
drial membrane can be formed in the absence of
mitochondrial-specific protein synthesis since cells
grown in the presence of the inhibitors appear to
have an approximately normal complement of
mitochondrial-like bodies with about the same
surface area as in control cells. The inner mito-
chondrial membrane behaves quite differently.
Both inhibitors cause its gradual disappearance.
The inner mitochondrial membrane which re-
mains is quite aberrant in form, and the infolding
into the shape of cristae rapidly disappears. The
mitochondrial protein-synthesizing system may
produce some crucial proteins of the inner mito-
chondrial membrane or proteins necessary to cor-
rectly anchor the inner mitochondrial membrane
to the outer membrane.
The appearance of lipid droplets in cells exposed
to mitochondrial-specific inhibitors may reflect an
interference with the fatty acid metabolism carried
out by mitochondria . However, such droplets ap-
pear to be generally characteristic of pathologic
states in cells and their appearance may not be a
direct consequence of aberrant mitochondrial func-
tion. The appearance of Golgi-like lamellar struc-
tures, while difficult to quantitate, is a striking
response to the inhibitors. Finally, the densely
staining bodies observed in the cells constitute a
type of structure whose origin and significance is
unknown.
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